ROLE OF THE P34CDC2 RELATED PITSLRE PROTEIN KINASES
P34CDC2 相关 PITSLRE 蛋白激酶的作用
基本信息
- 批准号:6194317
- 负责人:
- 金额:$ 28.02万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:1996
- 资助国家:美国
- 起止时间:1996-05-01 至 2006-04-30
- 项目状态:已结题
- 来源:
- 关键词:apoptosis cell cycle proteins cysteine endopeptidases enzyme activity enzyme induction /repression gene mutation gene targeting genetic markers genetically modified animals isozymes laboratory mouse melanocyte melanoma metastasis neoplasm /cancer genetics neoplastic process nucleic acid sequence polymerase chain reaction protein kinase single strand conformation polymorphism
项目摘要
Description (Adapted from the investigator's abstract): Recurring alterations
of chromosome 1 represent the most frequent site of structural chromosome
abnormalities across all human solid tumors, including human cutaneous
malignant melanoma. In melanoma, breakpoints involving chromosome 1 often
accumulate at 1p36. The two genes encoding the PITSLRE protein kinases, Cdc2L1
and Cdc2L2, are localized to chromosome band region 1p36. The PITSLRE protein
kinases are part of the p34cdc2 supergene family. Several lines of evidence
suggests that some of the PITSLRE protein kinases isoforms are involved in
apoptotic signal transduction. We have demonstrated deletion of Cdc2L alleles
in melanoma. We can also show that the p110 isoform of PITSLRE is cleaved by
caspases to a smaller p46 isoform. The p46 isoform retains kinase activity but
appears to change its substrate specificity. There is also a difference in the
sensitivity of melanoma cells (with wildtype and mutant Cdc2L alleles) to
apoptotic stimuli. Thus, the principal hypothesis to be tested is that the
caspase-processed PITSLRE isoform functions as a downstream effector in
apoptotic signaling pathways and that disruption of PITSLRE protein kinase
function plays a functional role in melanoma development by deregulating
controlled cell death. The three specific aims are: (1) To study the timing of
Cdc2L gene (PITSLRE) alteration during melanoma tumor progression using
PCR-SSCP and direct DNA sequencing. Archival sporadic melanoma cases from
various histological stages of melanoma are analyzed for mutations of specific
regions within the Cdc2L1 gene. In addition familial melanoma kindreds linked
to 1p are also investigated for Cdc2L1 gene alterations. (2) To isolate and
characterize the substrate for the caspase processed PITSLRE isoform using
yeast two hybrid methodology and (3) To elucidate the biological function of
Cdc2L gene inactivation by generating Cdc2L1 deficient mice. An increased
understanding of the critical gene alterations that give rise to the
development and progression of melanoma may lead to genetic markers for
melanoma. Defining the importance of Cdc2L1 alterations may be used to identify
interesting subpopulations. Genetic changes of Cdc2L1 also may have prognostic
value when considered in tandem with clinical data. Finally, increased
understanding of biological role of Cdc2L may lead to new and innovative
strategies to treat melanoma.
描述(改编自研究者摘要):复发性改变
1号染色体上的DNA是结构染色体上最常见的位点
所有人类实体瘤中的异常,包括人类皮肤
恶性黑素瘤在黑色素瘤中,涉及1号染色体的断裂点通常
累积到1 p36。编码PITSLRE蛋白激酶Cdc 2L 1的两个基因
和Cdc 2L 2定位于染色体带区1 p36。PITSLRE蛋白
激酶是p34 cdc 2超基因家族的一部分。若干条证据
表明PITSLRE蛋白激酶的某些亚型参与了
凋亡信号转导我们已经证明了Cdc 2L等位基因的缺失
黑色素瘤我们还可以证明PITSLRE的p110亚型被
半胱天冬酶转化为较小的p46同种型。p46同种型保留激酶活性,
似乎改变了它的底物特异性。也有区别
黑色素瘤细胞(具有野生型和突变型Cdc 2L等位基因)对
凋亡刺激。因此,要检验的主要假设是,
半胱天冬酶处理的PITSLRE同种型作为下游效应子在
细胞凋亡信号通路和PITSLRE蛋白激酶的破坏
在黑色素瘤的发展中起着功能性作用,
控制细胞死亡。三个具体目标是:(1)研究
Cdc 2L基因(PITSLRE)在黑色素瘤肿瘤进展过程中的改变
PCR-SSCP和DNA直接测序。档案散发性黑色素瘤病例
分析黑色素瘤的不同组织学阶段的特定突变,
Cdc 2L 1基因中的区域。此外,家族性黑色素瘤激酶相关
到1 p也研究Cdc 2L 1基因的改变。(2)分离和
使用以下物质表征半胱天冬酶加工的PITSLRE同种型的底物:
酵母双杂交方法;(3)阐明
通过产生Cdc 2L 1缺陷小鼠使Cdc 2L基因失活。增加
了解引起人类免疫缺陷的关键基因改变,
黑色素瘤的发展和进展可能导致遗传标记,
黑素瘤定义Cdc 2L 1改变的重要性可用于识别
有趣的亚群Cdc 2L 1的遗传改变也可能具有预后意义。
与临床数据相结合时的价值。最后,增加
了解Cdc 2L的生物学作用可能会导致新的和创新的
治疗黑色素瘤的策略。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Mark Anthony Nelson其他文献
Mark Anthony Nelson的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Mark Anthony Nelson', 18)}}的其他基金
Lung Cancer, DNA Methylation, and Liquid Biopsy
肺癌、DNA 甲基化和液体活检
- 批准号:
10257798 - 财政年份:2022
- 资助金额:
$ 28.02万 - 项目类别:
Mechanistic Effects of Organic Selenium Against Colon C
有机硒对结肠 C 的作用机制
- 批准号:
6768689 - 财政年份:2002
- 资助金额:
$ 28.02万 - 项目类别:
Mechanistic Effects of Organic Selenium Against Colon C
有机硒对结肠 C 的作用机制
- 批准号:
6925440 - 财政年份:2002
- 资助金额:
$ 28.02万 - 项目类别:
Mechanistic Effects of Organic Selenium Against Colon C
有机硒对结肠 C 的作用机制
- 批准号:
6618031 - 财政年份:2002
- 资助金额:
$ 28.02万 - 项目类别:
Mechanistic Effects of Organic Selenium Against Colon C
有机硒对结肠 C 的作用机制
- 批准号:
7101888 - 财政年份:2002
- 资助金额:
$ 28.02万 - 项目类别:
ROLE OF THE P34CDC2 RELATED PITSLRE PROTEIN KINASES
P34CDC2 相关 PITSLRE 蛋白激酶的作用
- 批准号:
7232138 - 财政年份:1996
- 资助金额:
$ 28.02万 - 项目类别:
ALTERATIONS IN THE PITSLRE PROTEIN KINASE IN MELANOMA
黑色素瘤中 PITSLRE 蛋白激酶的变化
- 批准号:
2114092 - 财政年份:1996
- 资助金额:
$ 28.02万 - 项目类别:
ALTERATIONS IN THE PITSLRE PROTEIN KINASE IN MELANOMA
黑色素瘤中 PITSLRE 蛋白激酶的变化
- 批准号:
2700665 - 财政年份:1996
- 资助金额:
$ 28.02万 - 项目类别:
ALTERATIONS IN THE PITSLRE PROTEIN KINASE IN MELANOMA
黑色素瘤中 PITSLRE 蛋白激酶的变化
- 批准号:
6173161 - 财政年份:1996
- 资助金额:
$ 28.02万 - 项目类别:
相似海外基金
MRC TS Award: Regulation of neutrophil functions by cell cycle proteins
MRC TS 奖:细胞周期蛋白调节中性粒细胞功能
- 批准号:
MR/X023087/1 - 财政年份:2023
- 资助金额:
$ 28.02万 - 项目类别:
Fellowship
Cell cycle proteins as key regulators of cardiac chemosensitivity
细胞周期蛋白作为心脏化疗敏感性的关键调节因子
- 批准号:
10353398 - 财政年份:2021
- 资助金额:
$ 28.02万 - 项目类别:
Cell cycle proteins as key regulators of cardiac chemosensitivity
细胞周期蛋白作为心脏化疗敏感性的关键调节因子
- 批准号:
10558622 - 财政年份:2021
- 资助金额:
$ 28.02万 - 项目类别:
Regulation of neutrophil functions by cell cycle proteins
细胞周期蛋白对中性粒细胞功能的调节
- 批准号:
MR/R02149X/1 - 财政年份:2018
- 资助金额:
$ 28.02万 - 项目类别:
Fellowship
Role of Musashi in the regulation of cell cycle proteins
Musashi 在细胞周期蛋白调节中的作用
- 批准号:
DP120100224 - 财政年份:2012
- 资助金额:
$ 28.02万 - 项目类别:
Discovery Projects
Interaction between HIV-1 and cell cycle proteins
HIV-1 和细胞周期蛋白之间的相互作用
- 批准号:
6594793 - 财政年份:2002
- 资助金额:
$ 28.02万 - 项目类别:
REGULATION OF CELL CYCLE PROTEINS DURING ANGIOGENESIS
血管生成过程中细胞周期蛋白的调节
- 批准号:
6497933 - 财政年份:2002
- 资助金额:
$ 28.02万 - 项目类别:
Interaction between HIV-1 and cell cycle proteins
HIV-1 和细胞周期蛋白之间的相互作用
- 批准号:
6608078 - 财政年份:2002
- 资助金额:
$ 28.02万 - 项目类别:














{{item.name}}会员




